July 17, 2023
Cost Plus Drugs, co-founded by Mark Cuban and radiologist Alexander Oshmyansky, will provide customers the ability to purchase Yusimry, a biosimilar for Humira, for $569.27 plus dispensing and shipping fees. Humira is currently priced at $6,922 for the same quantity.
Members of Cost Plus Drugs can get Yusimry at this discounted price, as can members of RxPreferred and SmithRx, two pharmacy benefits administrators who have partnered with Cost Plus Drugs.
This pricing by Cost Plus Drugs makes it easier and more affordable for patients to get the treatment they need. Cuban said the company hopes to provide other biosimilar drugs as well. “Our mission is to be the low-cost provider of any and all medications we are able to carry,” he wrote.